IBDEI0Y4 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16931,1,1,0)
 ;;=1^J9390
 ;;^UTILITY(U,$J,358.3,16931,1,3,0)
 ;;=3^Navelbine 10mg
 ;;^UTILITY(U,$J,358.3,16932,0)
 ;;=J9171^^109^1065^32^^^^1
 ;;^UTILITY(U,$J,358.3,16932,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16932,1,1,0)
 ;;=1^J9171
 ;;^UTILITY(U,$J,358.3,16932,1,3,0)
 ;;=3^Docetaxel 1 mg
 ;;^UTILITY(U,$J,358.3,16933,0)
 ;;=J9070^^109^1065^20^^^^1
 ;;^UTILITY(U,$J,358.3,16933,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16933,1,1,0)
 ;;=1^J9070
 ;;^UTILITY(U,$J,358.3,16933,1,3,0)
 ;;=3^Cyclophosphamide 100mg Inj
 ;;^UTILITY(U,$J,358.3,16934,0)
 ;;=J9351^^109^1065^84^^^^1
 ;;^UTILITY(U,$J,358.3,16934,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16934,1,1,0)
 ;;=1^J9351
 ;;^UTILITY(U,$J,358.3,16934,1,3,0)
 ;;=3^Topotecan Inj 0.1mg
 ;;^UTILITY(U,$J,358.3,16935,0)
 ;;=J9035^^109^1065^11^^^^1
 ;;^UTILITY(U,$J,358.3,16935,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16935,1,1,0)
 ;;=1^J9035
 ;;^UTILITY(U,$J,358.3,16935,1,3,0)
 ;;=3^Bevacizumab Inj,10mg
 ;;^UTILITY(U,$J,358.3,16936,0)
 ;;=J9041^^109^1065^13^^^^1
 ;;^UTILITY(U,$J,358.3,16936,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16936,1,1,0)
 ;;=1^J9041
 ;;^UTILITY(U,$J,358.3,16936,1,3,0)
 ;;=3^Bortezomib Inj, 0.1mg
 ;;^UTILITY(U,$J,358.3,16937,0)
 ;;=J9055^^109^1065^17^^^^1
 ;;^UTILITY(U,$J,358.3,16937,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16937,1,1,0)
 ;;=1^J9055
 ;;^UTILITY(U,$J,358.3,16937,1,3,0)
 ;;=3^Cetuximab Inj, 10mg
 ;;^UTILITY(U,$J,358.3,16938,0)
 ;;=J8530^^109^1065^21^^^^1
 ;;^UTILITY(U,$J,358.3,16938,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16938,1,1,0)
 ;;=1^J8530
 ;;^UTILITY(U,$J,358.3,16938,1,3,0)
 ;;=3^Cyclophosphamide Oral, 25mg
 ;;^UTILITY(U,$J,358.3,16939,0)
 ;;=J9206^^109^1065^53^^^^1
 ;;^UTILITY(U,$J,358.3,16939,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16939,1,1,0)
 ;;=1^J9206
 ;;^UTILITY(U,$J,358.3,16939,1,3,0)
 ;;=3^Irinotecan Inj, 20mg
 ;;^UTILITY(U,$J,358.3,16940,0)
 ;;=J0135^^109^1065^2^^^^1
 ;;^UTILITY(U,$J,358.3,16940,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16940,1,1,0)
 ;;=1^J0135
 ;;^UTILITY(U,$J,358.3,16940,1,3,0)
 ;;=3^Adalimumab Inj 20mg
 ;;^UTILITY(U,$J,358.3,16941,0)
 ;;=Q2050^^109^1065^36^^^^1
 ;;^UTILITY(U,$J,358.3,16941,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16941,1,1,0)
 ;;=1^Q2050
 ;;^UTILITY(U,$J,358.3,16941,1,3,0)
 ;;=3^Doxorubicin Inj 10mg
 ;;^UTILITY(U,$J,358.3,16942,0)
 ;;=J0129^^109^1065^1^^^^1
 ;;^UTILITY(U,$J,358.3,16942,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16942,1,1,0)
 ;;=1^J0129
 ;;^UTILITY(U,$J,358.3,16942,1,3,0)
 ;;=3^Abatacept Inj 10mg
 ;;^UTILITY(U,$J,358.3,16943,0)
 ;;=J0256^^109^1065^4^^^^1
 ;;^UTILITY(U,$J,358.3,16943,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16943,1,1,0)
 ;;=1^J0256
 ;;^UTILITY(U,$J,358.3,16943,1,3,0)
 ;;=3^Alpha 1 Proteinase Inh Inj 10mg
 ;;^UTILITY(U,$J,358.3,16944,0)
 ;;=J0461^^109^1065^7^^^^1
 ;;^UTILITY(U,$J,358.3,16944,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16944,1,1,0)
 ;;=1^J0461
 ;;^UTILITY(U,$J,358.3,16944,1,3,0)
 ;;=3^Atropine Sulfate Inj 0.01mg
 ;;^UTILITY(U,$J,358.3,16945,0)
 ;;=J0881^^109^1065^26^^^^1
 ;;^UTILITY(U,$J,358.3,16945,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16945,1,1,0)
 ;;=1^J0881
 ;;^UTILITY(U,$J,358.3,16945,1,3,0)
 ;;=3^Darbepoetin Alfa 1mcg
 ;;^UTILITY(U,$J,358.3,16946,0)
 ;;=J1094^^109^1065^30^^^^1
 ;;^UTILITY(U,$J,358.3,16946,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16946,1,1,0)
 ;;=1^J1094
 ;;^UTILITY(U,$J,358.3,16946,1,3,0)
 ;;=3^Dexamethason Acetate Inj 1mg
 ;;^UTILITY(U,$J,358.3,16947,0)
 ;;=J1642^^109^1065^45^^^^1
 ;;^UTILITY(U,$J,358.3,16947,1,0)
 ;;=^358.31IA^3^2
